The pet insurance sector faces significant challenges due to gaps in data provision and limited visibility, leading to inflated costs that other areas of the insurance industry addressed years ago. The lack of visibility and understanding of pricing across vets, medications, and treatments makes it difficult for insurers to control the cost and for underwriters to price the policies correctly and monitor trends. Without detailed, accurate data, insurers and underwriters struggle to make informed decisions, leading to inefficiencies, overpayments, and lower profitability. Historically, these issues have remained unsolved due to the lack of a tailored solution.

The lack of clarity in treatment and medicines costs, conditions trend analysis and treatment advancements are not just an operational hurdle – it’s a financial risk. Without accurate cost mapping, the industry continues to operate with inflated costs that drain resources. These factors significantly impact both claims and underwriting teams, especially when underwriters lack visibility into underlying inflation, treatment advancements and underlying trends. Without access to this analysis, including pricing dynamics and insights from vet group performance, claims costs can become inflated, ultimately affecting the profitability and sustainability of pet insurance providers. By addressing these gaps, companies can gain control over claims processes, increase profitability, have more control over supply chain and align pricing with actual costs. Solving this problem leads to more competitive pricing, better customer outcomes, and improved financial health for insurers.